NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹105.33 | ₹77.56 | ₹39.19 | ₹9.32 | ₹24.16 |
What is the latest Earnings Per Share (EPS) of NATCO PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹105.33 |
| Mar2024 | ₹77.56 |
| Mar2023 | ₹39.19 |
| Mar2022 | ₹9.32 |
| Mar2021 | ₹24.16 |
How is Earnings Per Share (EPS) of NATCO PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹105.33 | 35.80 | |
| Mar2024 | ₹77.56 | 97.91 | |
| Mar2023 | ₹39.19 | 320.49 | |
| Mar2022 | ₹9.32 | -61.42 | |
| Mar2021 | ₹24.16 | - | |
Compare Earnings Per Share (EPS) of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,426.2 Cr | -1.3% | -4.6% | -4.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -1.3% |
-4.6% |
-4.3% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses